Deutsche Bank
AVDL

Deutsche Bank’s Avadel Pharmaceuticals AVDL Stock Holding History

Deutsche Bank’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-754,378
Closed -$11.5M – 3630
2025
Q3 		$11.5M Buy
754,378
+51,096
+7% +$665K ﹤0.01% 1012
2025
Q2 		$6.22M Buy
703,282
+198,492
+39% +$1.74M ﹤0.01% 1152
2025
Q1 		$3.95M Sell
504,790
-3,906
-0.8% -$32.7K ﹤0.01% 1354
2024
Q4 		$5.35M Buy
508,696
+32,227
+7% +$391K ﹤0.01% 1300
2024
Q3 		$6.25M Sell
476,469
-127,666
-21% -$1.94M ﹤0.01% 1186
2024
Q2 		$8.49M Buy
604,135
+39,135
+7% +$638K ﹤0.01% 1057
2024
Q1 		$9.54M Buy
565,000
+125,000
+28% +$1.86M ﹤0.01% 1038
2023
Q4 		$6.21M Hold
440,000
– – ﹤0.01% 1164
2023
Q3 		$4.53M Buy
440,000
+215,000
+96% +$2.88M ﹤0.01% 1063
2023
Q2 		$3.71M Buy
+225,000
New +$2.92M ﹤0.01% 1348
2022
Q4 		– Sell
-67,482
Closed -$338K – 4008
2022
Q3 		$338K Sell
67,482
-57,518
-46% -$317K ﹤0.01% 2621
2022
Q2 		$305K Sell
125,000
-218,407
-64% -$897K ﹤0.01% 2904
2022
Q1 		$2.35M Hold
343,407
– – ﹤0.01% 1793
2021
Q4 		$2.77M Hold
343,407
– – ﹤0.01% 1787
2021
Q3 		$3.37M Sell
343,407
-137,787
-29% -$1.08M ﹤0.01% 1734
2021
Q2 		$3.24M Buy
481,194
+53,518
+13% +$425K ﹤0.01% 1821
2021
Q1 		$3.87M Hold
427,676
– – ﹤0.01% 1704
2020
Q4 		$2.86M Sell
427,676
-17,381
-4% -$109K ﹤0.01% 1679
2020
Q3 		$2.24M Buy
445,057
+17,381
+4% +$126K ﹤0.01% 1675
2020
Q2 		$3.46M Sell
427,676
-160,631
-27% -$1.42M ﹤0.01% 1497
2020
Q1 		$4.67M Hold
588,307
– – ﹤0.01% 1284
2019
Q4 		$4.44M Hold
588,307
– – ﹤0.01% 1516
2019
Q3 		$2.45M Sell
588,307
-1,369
-0.2% -$3.43K ﹤0.01% 1790
2019
Q2 		$1.7M Sell
589,676
-11,024
-2% -$18.9K ﹤0.01% 2502
2019
Q1 		$864K Buy
600,700
+576,795
+2,413% +$1.3M ﹤0.01% 3082
2018
Q4 		$61K Sell
23,905
-753,184
-97% -$2.56M ﹤0.01% 4404
2018
Q3 		$3.41M Sell
777,089
-377,673
-33% -$2.04M ﹤0.01% 2487
2018
Q2 		$7.08M Sell
1,154,762
-86,670
-7% -$608K ﹤0.01% 2031
2018
Q1 		$9.05M Buy
1,241,432
+138,250
+13% +$1.22M ﹤0.01% 1709
2017
Q4 		$9.04M Sell
1,103,182
-9,160
-0.8% -$85.9K 0.01% 1579
2017
Q3 		$11.7M Sell
1,112,342
-428,204
-28% -$4.09M 0.01% 1349
2017
Q2 		$17M Buy
1,540,546
+358,336
+30% +$3.6M 0.01% 1043
2017
Q1 		$11.4M Sell
1,182,210
-412,122
-26% -$4.12M 0.01% 1175
2016
Q4 		$16.6M Buy
1,594,332
+301,604
+23% +$3.31M 0.01% 969
2016
Q3 		$16M Sell
1,292,728
-118,943
-8% -$1.55M 0.01% 1026
2016
Q2 		$15.2M Sell
1,411,671
-375,594
-21% -$4M 0.01% 1063
2016
Q1 		$19.7M Sell
1,787,265
-371,380
-17% -$3.69M 0.01% 906
2015
Q4 		$26.4M Buy
2,158,645
+51,327
+2% +$800K 0.02% 810
2015
Q3 		$34.4M Buy
2,107,318
+431,953
+26% +$9.51M 0.03% 624
2015
Q2 		$35.5M Buy
1,675,365
+509,077
+44% +$9.13M 0.02% 670
2015
Q1 		$21M Buy
1,166,288
+949,664
+438% +$14.9M 0.01% 909
2014
Q4 		$3.71M Buy
216,624
+95,417
+79% +$1.36M ﹤0.01% 2197
2014
Q3 		$1.73M Buy
121,207
+16,967
+16% +$244K ﹤0.01% 2617
2014
Q2 		$1.56M Sell
104,240
-36,772
-26% -$444K ﹤0.01% 2612
2014
Q1 		$1.89M Buy
141,012
+129,812
+1,159% +$1.39M ﹤0.01% 2440
2013
Q4 		$90K Buy
11,200
+4,700
+72% +$33.2K ﹤0.01% 4102
2013
Q3 		$42K Sell
6,500
-106,678
-94% -$656K ﹤0.01% 4728
2013
Q2 		$694K Buy
+113,178
New +$585K ﹤0.01% 2956

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's AVDL Position: Q4 2025 in Review

Deutsche Bank sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 754,378 shares — an estimated $11.5M sold.

Deutsche Bank first reported a position in AVDL in Q2 2013 and held it in 48 quarters. The position peaked at $35.5M in Q2 2015. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Deutsche Bank reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Deutsche Bank sold 754,378 Avadel Pharmaceuticals shares in Q4 2025, an estimated $11.5M.
  • Deutsche Bank first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 48 quarters.
  • Deutsche Bank's Avadel Pharmaceuticals position peaked at $35.5M in Q2 2015.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.